Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Hariprasad Trivedi MD
Professor
Department of Medicine
Division of Nephrology

OFFICE ADDRESS:
Clinical Cancer Center
9200 W Wisconsin Ave
Milwaukee, WI 53226

CITIZENSHIP:  USA

EDUCATION:
6/1977 - 4/1979 Higher Secondary Certificate (H.S.C.), Kishinchand Chellaram College Mumbai, India
7/1979 - 12/1984 Bachelor of Medicine & Bachelor of Surgery, (M.B.B.S.), Internal Medicine
1/1985 - 1/1988 Doctor of Medicine (M.D.) Medicine & Therapeutics, Grant Medical College
5/1989 - 5/1991 Doctor of Medicine (D.M.) Nephrology, Seth G. S. Medical College Mumbai, India
Mumbai, India
Grant Medical College, Mumbai, India

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
7/1992 - 6/1994 Fellow in Nephrology, University of Missouri-Columbia, Columbia, Mo,
7/1994 - 6/1996 Resident in Internal Medicine, University of Missouri-Columbia, Columbia, MO,
Clinical,

FACULTY APPOINTMENTS:
7/1996 - 10/2004 Staff Nephrologist, Harry S. Truman Memorial Veterans' Hospital,
5/1997 - 12/2003 Assistant Prof of Medicine, University of Missouri-Columbia,
1/2004 - 10/2004 Associate Professor of Medicine, University of Missouri-Columbia,
11/2004 - 6/2011 Associate Professor of Medicine, Medical College of Wisconsin,
7/2011 - Present Professor of Medicine, Medical College of Wisconsin,
Milwaukee WI 53226,
Milwaukee WI 53226,
Columbia, MO 65212,
Columbia, MO 65212,
Columbia, MO 65212,

ADMINISTRATIVE APPOINTMENTS:
9 - Present HOSPITAL ADMINISTRATIVE EXPERIENCE:,
8/1995 - Present Member of Continuum of Care Function Team that helped prepare for JCAHO visit at the Harry S. Truman Memorial Veterans Hospital,
7/2004 - 10/2004 Clinical Executive Board, Harry S. Truman Memorial Veterans' Hospital,
7/2010 - Present Director, Dialysis Services, Medical College of Wisconsin,
Ad Hoc Served as Acting Chief of Service (VA Hospital) on several occasions.,
Ad Hoc Served as Acting Chief of Staff (VA Hospital),

RESEARCH ADMINISTRATIVE APPOINTMENTS:
1/2000 - 12/2003 Research and Development Committee, Harry S. Truman Memorial Veterans Hospital,
7/2000 - 6/2002 Institutional Review Board, University of Missouri-Columbia,

HOSPITAL STAFF PRIVILEGES:
7/1996 - 10/2004 Harry S. Truman Veterans' Hospital, Columbia, MO.,
5/1997 - 10/2004 University Hospital, Columbia, MO.,
11/2004 - Present Froedtert Memorial Lutheran Hospital, Milwaukee WI,

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
ABIM - Nephrology Sub-specialty
11/1997
12/2017
 
Licensure
Number Issue DateExpiration
Wisconsin
47430
7/2004
10/2013
 
AWARDS AND HONORS:
10/1983 - Present MB; BS (III): Ranked 3rd out of 150 students at Final MBBS examination in Grant Medical College.
1/1985 - 1/1988 Awarded University Merit Scholarship during training for MD.
3/1986 - Present Internal Medicine: Kohiyar Prize for ranking 1st among the Post graduate students registered for Internal Medicine, MD
1/1988 - Present Internal Medicine: Ranked 3 out of 70 students at MD (Internal Medicine Boards) at the Bombay University Examination.
10/1994 - Present Internal Medicine: Second author in the Best Abstract award (research category) in the 1994 University of Missouri-Columbia ACP Associates Abstract competition for the abstract titled "Acute
7/2011 - Present Froedtert Hospital received high national ranking in five specialties, including nephrology in U.S. News & World Report's 2011-12 "Best Hospitals" list
7/2011 - Present Received Medical College of Wisconsin Outstanding Faculty Service Award in recognition of service to the Continuing Medical Education Committee.

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
7/2007 - Present Member (American Society of Nephrology)

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
1. "Outcomes in patients with chronic kidney disease referred late to nephrologists", Medical Grand Rounds
 
National
1. 4. "Contrast Nephropathy" Texas Tech University, Odessa Campus, Odesssa, TX, 7/2003 - Present
2. 3. "Cardiovascular Disease and Chronic Kidney Disease" Renal Grand Rounds -Medical College of Virginia and Virginia Commonwealth University, Richmond, VA, 9/2003 - Present
3. 2. "Chronic Kidney Disease and Cardiovascular Disease" St. Louis University and John Cochran VA Medical Center, St. Louis, MO, 10/2003 - Present
4. 1. "Contrast Nephropathy" Medicine Grand Rounds, Medical College of Georgia, Auguasta, GA, 10/2003 - Present
5. 5. "What Are the Real Risks of Radiocontrast?" National Kidney Foundation, Spring Meeting, Las Vegas, NV, 4/2011 - Present
6. 6. "Atrial Fibrillation: Rethinking Digoxin and Warfarin in Hemodialysis Patients" American Society of Nephrology Annual Meeting, San Francisco, CA, 11/2011 - Present
 
MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
2/2011 - 3/2011 Activity Information: Preceptor for Clinical Examination and Reasoning (CER) course -second-year medical students (M2)
 
Resident and Fellow Education
11/2004 - Present Activity Information: Ongoing education during clinical rounds, lectures, case conferences
 
Postdoctoral Fellow Education
6/2005 - Present Activity Information: Preceptor of ACGME-required fellow journal club teaching clinical research methods, pertinent statistical interpretation, and critical review of articles published in lead journal
 
EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Clinical/Research Fellows
9/2008 - 3/2010 Fellow: Rama Nadella
Capacity Research Project mentor
 
Residents
7/2005 - 6/2006 Resident: Ruchika Batwara
7/2006 - 6/2007 Resident: Niddhi Aggarwal
Capacity Research mentor.
Capacity Research mentor.
 

BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. TRIVEDI H, Joshi MN. Non-compressive myelopathy: A Synopsis. The Indian Practitioner August 1991; 583-587
2. TRIVEDI H, Gulane M, Almeida AF, Acharya VN. The Effect of Successful Renal Transplantation on Visual Evoked Potentials and Brainstem Auditory Evoked Responses. Trans Proc 1992; 24: 1753.
3. Dikshit MP, Acharya VN, TRIVEDI H, Almeida AF. Plasma Exchange vs. Cyclosporine Retrieval Therapy in Steroid Resistant Acute Rejection of Renal Allografts. Trans Proc 1992; 24: 1724.
4. TRIVEDI H, Nolph KD. Nephrogenic Diabetes Insipidus presenting after Head Trauma. Am J Nephrol 1994; 14: 145-147.
5. TRIVEDI H, Twardowski ZJ. Long-term Successful Nocturnal Intermittent Peritoneal Dialysis: A Ten-year Case Study. Adv Perit Dial 1994; 10: 81-84.
6. Lal SM, TRIVEDI H, Van Stone J, Ross G, Jr. Effect of Dietary Therapy on Post-transplant Hyperlipidemia: A Prospective Study. Int J Artif Intern Organs 1994; 17: 461-65.
7. TRIVEDI H, Khanna R, Lo WK, Prowant B, Nolph K. Reproducibility of the Peritoneal Equilibration Test in CAPD patients. ASAIO J 1994; 40:M892-M895.
8. Lal SM, TRIVEDI H, Van Stone J, Ross G Jr. Long-term effects of angiotensin converting enzyme inhibitors on post-transplant erythrocytosis. Int J Artif Intern Organs 1995; 18:13-16.
9. Samuel J, TRIVEDI H, Reams G. Hypertension case and comment: A crystal clear case. Patient Care 1995; 29:138 -144.
10. TRIVEDI H, Lal SM, Ross G, Jr: Coagulopathy Induced by Polyclonal Antibodies. Int J Artif Intern Organs 1996; 19:448-50.
11. TRIVEDI H, Lal SM, Ross G Jr: Hypocholesterolemia is not associated with Cyclosporine Neurotoxicity. Int J Artif Intern Organs 1996; 19:343-346.
12. TRIVEDI HS, Twardowski ZJ: Use of Double lumen Hemodialysis Catheters: Loading with locked heparin. ASAIO J 1997; 43: 900-903.
13. TRIVEDI H, Pang MMH, Campbell A, Saab P. Slowing the progression of chronic renal failure: Economic benefits and patients' perspectives Am J Kidney Dis 2002; 39:721-729.
14. TRIVEDI H, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, Hewett J. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003; 93: c29-c34.
15. TRIVEDI H, Brooks BJ. Erythropoietin therapy in pre-dialysis patients with chronic renal failure: lack of need for parenteral iron. Am J Nephrol 2003; 23: 78-85.
16. TRIVEDI H, Lal SM. A prospective, randomized, open-labeled cross over trial of fosinopril and theophylline in post renal transplant erythrocytosis. Ren Fail 2003; 25: 77-86.
17. TRIVEDI H, Pang MMH. Discrepancy in the epidemiology of non-diabetic chronic renal insufficiency end-stage renal disease in black and white Americans: the Third National Health and Nutrition Examination Survey and United States Renal Data System Am J Nephrol 2003; 23: 448 - 457.
18. TRIVEDI H, TRIVEDI MH. Subnormal erythropoietin response in patients receiving interferon- ribavirin combination therapy for hepatitis C. J Clin Gastrol 2004; 38: 595-598.
19. TRIVEDI H, Moore H, Atalla J. Lack of significant circadian and post-prandial variation in phosphate levels in hospitalized subjects receiving chronic hemodialysis therapy. J Nephrol 2005; 18: 417-422.
20. TRIVEDI H, Tan SH, Prowant B, Sherman A, Voinescu CG, Atalla J, Khanna R, Nolph KD. Predictors of death in patients on peritoneal dialysis - The Missouri peritoneal dialysis study. Am J Nephrol 2005; 25: 466-473.
21. TRIVEDI H, Dresser T, Aggarwal K. Acute effect of furosemide on glomerular filtration rate in diastolic dysfunction. Ren Fail 2007; 29:985-989.
22. TRIVEDI H, Tan SH, Prowant B, Sherman A, Voinescu CG, Atalla J, Khanna R, Nolph KD. Predictors of hospitalization in patients on peritoneal dialysis - The Missouri experience. Am J Nephrol 2007;27:483-487.
23. Chan M, Dall A, Lu N, Fletcher K, TRIVEDI H. Outcomes in patients with chronic kidney disease referred late to nephrologists- a meta-analysis. Am J Med 2007; 120: 1063-1070.
24. TRIVEDI H, Kukla A, Prowant B, Lim H. A prospective study of the extracorporeal rate of blood flow and blood pressure during hemodialysis. Hemodial Int 2007; 11: 424-429.
25. TRIVEDI H. Is There Enough Evidence to Support Use of N-Acetylcysteine in Contrast-Induced Nephropathy? Ann Intern Med 2008; 149: 213.
26. TRIVEDI H, Xiang Q, Klein JP. Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients. Nephrol Dial Transplant 2009; 24: 258 - 266.
27. TRIVEDI H, Daram S, Szabo A, Bartorelli A, Marenzi G. High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy. Am J Med 2009; 122: 874.e9-874.e15.
28. Liang M, Liu Y, Mladinov D, Cowley AW, TRIVEDI H, Fang Y, Xu X, Ding X, Tian Z. MicroRNA: a new frontier in kidney and blood pressure research. Am J Physiol Renal Physiol 2009; 297: F553 - F558.
29. TRIVEDI H, Lu N, Andreson BT, Whaly-Connell A. Slower decline of renal function after initiation of rosiglitazone in diabetics- a pilot study. Clin Nephrol 2009; 72: 181-185.
30. TRIVEDI H, Raman L, Benjamin H, Batwara R. Lack of nephrotoxicity of gadodiamide in unselected hospitalized patients. Postgrad Med 2009; 121: 166-170.
31. TRIVEDI H. Cost implications of caring for CKD: Are interventions cost-effective? Adv Chronic Kidney Dis 2010; 17: 265-270.
32. TRIVEDI H, Foley WD. Contrast-induced nephropathy after a second contrast exposure. Ren Fail 2010; 32: 796-801.
33. TRIVEDI H, Nadella R, Szabo A. Hydration with sodium bicarbonate for the prevention of contrast-induced nephropathy: A meta-analysis of randomized controlled trials. Clin Nephrol 2010; 74: 288-296.
34. TRIVEDI H, Szabo A, Hariharan S. Declining rates of deceased donor renal transplantation in the United States over successive years of listing. Am J Med 2012; 125:57-65.
35. Raff H, TRIVEDI H. Circadian rhythm of salivary cortisol, plasma cortisol, and plasma ACTH
36. in end-stage renal disease. Endocr Connect 2013; 1: 134-142. DOI: 10.1530/EC-12-0058
37. PRESENTATIONS:
38. TRIVEDI H, Gulane M, Almeida AF, Acharya VN: The effect of successful renal transplantation on visual and brainstem auditory evoked responses. First International Congress on Transplantation in Developing Countries, Singapore 1992.
39. Dikshit MP, Acharya VN, TRIVEDI H, Almeida AF: Plasma exchange vs. Cyclosporine retrieval therapy in steroid-resistant acute rejection of renal allografts. First International Congress on Transplantation in Developing Countries, Singapore 1992.
40. TRIVEDI H, Khanna R, Prowant B, Twardowski ZJ, Nolph KD, Gamboa S: Reproducibility of the peritoneal equilibration test. Central Society for Clinical Research, Chicago, Illinois; November 3- 5, 1993. Clinical Research 1993; 41(3):655A.
41. TRIVEDI H, Twardowski ZJ: Successful nocturnal intermittent peritoneal dialysis for 10 years. XIVth Annual Conference on Peritoneal Dialysis, Orlando, Florida; January 24- 26, 1994. Perit Dial Int 1994;14 (suppl.1):S3.
42. TRIVEDI H, Khanna R, Gamboa S, Prowant B, Nolph KD, Twardowski ZJ: How reproducible is the peritoneal equilibration test (PET)? XIVth Annual Conference on Peritoneal Dialysis, Orlando, Florida; January 24- 26, 1994. Perit Dial Int 1994; 14(suppl.1):S3.
43. TRIVEDI H, Arfeen S, Goodship THJ, Ward MK: 1% Amino acid peritoneal dialysate: Single-cycle study in diabetics with end-stage renal disease. XIVth Annual Conference on Peritoneal Dialysis, Orlando, Florida; January 24- 26, 1994. Perit Dial Int 1994; 14(suppl.1):S3.
44. TRIVEDI H, Almeida AF, Khanna R: Visual and brain stem auditory evoked potentials in chronic renal failure. Third Annual Spring Clinical Nephrology Meeting of the National Kidney Foundation, Chicago, Illinois; April 7- 10, 1994.
45. Lal SM, TRIVEDI H, Van Stone J, Ross G Jr: Long- term effects of angiotensin-converting inhibitors on the erythrocytosis in renal transplant recipients. Central Society for Clinical Research, Chicago, Illinois, September 16- 18, 1994.
46. Trivedi MH, TRIVEDI H, Desai HG, Khanna R: Acute effects of Isosorbide 5- mononitrate in portal hypertension. Regional Meeting of the American College of Physicians, Missouri Chapter, Lake of the Ozarks, Missouri; October 14-16, 1994. (Awarded first prize in the University of Missouri- Columbia ACP Associates Abstract competition).
47. Misra A, TRIVEDI H, Lal SM: Polyclonal antibody-associated coagulopathy. Regional Meeting of the American College of Physicians, Missouri Chapter, Lake of the Ozarks, Missouri; October 14- 16, 1994.
48. Akhtar A, TRIVEDI H, Imam T, Bauer J: Role of angiotensin- converting enzyme inhibitors in primary aldosteronism. Regional Meeting of the American College of Physicians, Missouri Chapter, Lake of the Ozarks, Missouri; October 14-16, 1994.
49. Trivedi MH, TRIVEDI H, Salzer W: Bacteremic Pasteurella multocida pneumonia in an abattoir with cirrhosis. Regional Meeting of the American College of Physicians, Missouri Chapter, Lake of the Ozarks, Missouri; October 14-16, 1994.
50. Lal SM, TRIVEDI H, Van Stone J, Ross G Jr. Long-term effects of angiotensin-converting inhibitors on the erythrocytosis in renal transplant patients. 41st Annual conference of the American Society of Artificial Internal Organs, Chicago, Illinois; May 4-6, 1995. ASAIO J 1995; 41: 54.
51. TRIVEDI H, Thanigaraj S, Taraben A, Hata JS: Case Report of an 11-year old catheter fragment in the pulmonary artery after in situ breakage. Regional Meeting of the American College of Physicians, Missouri Chapter, Lake of the Ozarks, Missouri; Sept. 29-Oct.1, 1995.
52. TRIVEDI H, Lal SM: Long-term effects of angiotensin-converting inhibitors on the erythrocytosis in renal transplant patients. Regional Meeting of the American College of Physicians, Missouri Chapter, Lake of the Ozarks, Missouri; Sept. 29- Oct. 1,1995.
53. TRIVEDI H: Centuries' old Enigma. Medical Grand Rounds, of Internal Medicine, University of Missouri-Columbia, Sept. 14, 1995.
54. TRIVEDI H, Twardowski ZJ: Use of double lumen hemodialysis catheters: Loading with locked heparin. XVIth Annual Conference on Peritoneal Dialysis, Seattle, Washington, Feb. 21-23, 1996. Perit Dial Int 1996; 16 (Suppl 2): S100.
55. Imam T, Akhtar A, TRIVEDI H. Role of angiotensin converting enzyme inhibitors (ACEI) in primary aldosteronism (PA). National Kidney Foundation Spring Clinical Meeting 1996, Anaheim, CA. Am J Kidney Dis 1996; 27:A8.
56. TRIVEDI H, Dresser T, Aggarwal K: Acute effect of diuretic therapy on the glomerular filtration rate in patients with diastolic dysfunction. World Congress of Nephrology Oct. 2001, San Francisco, CA. J Am Soc Nephrol 2001; 12: 518A.
57. TRIVEDI H, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, Hewett J: A randomized controlled trial to assess the effect of hydration in the development of contrast nephropathy. World Congress of Nephrology Oct. 2001, San Francisco, CA. J Am Soc Nephrol 2001; 12: 184A.
58. TRIVEDI H, Pang MMH, Campbell A, Saab P: Slowing the progression of chronic renal failure: Economic aspects and patient perspectives. World Congress of Nephrology Oct. 2001, San Francisco, CA. J Am Soc Nephrol 2001; 12: 86A.
59. Whaley-Connell A, Tarakji A, TRIVEDI H: Renal amyloidosis in a diabetic with hydronephrosis: a wolf in a sheep's clothing. Regional Meeting of the American College of Physicians, Missouri Chapter, September 2002; Lake of the Ozarks, Missouri.
60. TRIVEDI H, Brooks BJ: Erythropoietin therapy in pre-dialysis patients with chronic renal failure: lack of need for parenteral iron. Annual Meeting of the American Society of Nephrology Oct-Nov 2002, Philadelphia, PA. J Am Soc Nephrol 2002; 13: 463A - 464A.
61. TRIVEDI H, Pang MMH: Discrepancy in the epidemiology of non-diabetic chronic renal insufficiency end-stage renal disease in black and white Americans: the Third National Health and Nutrition Examination Survey and United States Renal Data System Annual Meeting of the American Society of Nephrology Nov 2003, San Diego, CA. J Am Soc Nephrol 2003: 191A.
62. TRIVEDI H, Trivedi MH: Subnormal erythropoietin response in patients receiving interferon- ribavirin combination therapy for hepatitis C. Annual Meeting of the American Society of Nephrology Nov 2003, San Diego, CA. J Am Soc Nephrol 2003; 14: 708A.
63. TRIVEDI H, Dresser T, Aggarwal K: Acute effect of loop diuretic therapy on glomerular filtration rate in normal individuals and patients with diastolic dysfunction. Annual Meeting of the American Society of Nephrology Nov 2003, San Diego, CA. J Am Soc Nephrol 2003: 768A.
64. TRIVEDI H, Kaufman J: Event rates of non-fatal myocardial infarction and cardiac death in incident dialysis patients without history of coronary artery disease. Annual Meeting of the American Society of Nephrology 2004, St. Louis, MO. J Am Soc Nephrol 2004; 15: 401A.
65. Atalla J, Tan SH, Prowant B, Khanna R, Nolph KD, TRIVEDI H: Baseline predictors of death in patients initiated on peritoneal dialysis. The Missouri Peritoneal Dialysis Study I. Annual Meeting of the American Society of Nephrology 2004, St. Louis, MO. J Am Soc Nephrol 2004; 15: 603A.
66. Atalla J, Tan SH, Prowant B, Khanna R, Nolph KD, TRIVEDI H: Baseline predictors of hospitalization in patients initiated on peritoneal dialysis. The Missouri Peritoneal Dialysis Study II. Annual Meeting of the American Society of Nephrology 2004, St. Louis, MO. J Am Soc Nephrol 2004; 15: 603A.
67. Atalla J, Tan SH, Prowant B, Khanna R, Nolph KD, TRIVEDI H: Baseline predictors of technique failure in patients initiated on peritoneal dialysis. The Missouri Peritoneal Dialysis Study III. Annual Meeting of the American Society of Nephrology 2004, St. Louis, MO. J Am Soc Nephrol 2004; 15: 603A.
68. TRIVEDI H, Tan SH, Prowant B, Atalla J, Khanna R, Nolph KD: Predictors of death during peritoneal dialysis. The Missouri Peritoneal Dialysis Study IV. Annual Meeting of the American Society of Nephrology 2004, St. Louis, MO. J Am Soc Nephrol 2004; 15: 601A.
69. TRIVEDI H, Tan SH, Prowant B, Atalla J, Khanna R, Nolph KD: Predictors of hospitalization during peritoneal dialysis. The Missouri Peritoneal Dialysis Study V. Annual Meeting of the American Society of Nephrology 2004, St. Louis, MO. J Am Soc Nephrol 2004; 15: 602A.
70. TRIVEDI H, Tan SH, Prowant B, Atalla J, Khanna R, Nolph KD: Predictors of technique failure during peritoneal dialysis. The Missouri Peritoneal Dialysis Study VI. Annual Meeting of the American Society of Nephrology 2004, St. Louis, MO. J Am Soc Nephrol 2004; 15: 602A.
71. TRIVEDI H, Kaufman J: Rates of non-fatal myocardial infarction and cardiac death in incident dialysis subjects without a documented history of coronary artery disease. Annual Meeting of the American Society of Nephrology 2005, Philadelphia, PA. J Am Soc Nephrol 2005; 16: 298A.
72. TRIVEDI H, Kukla A, Prowant B, Eastwood D, Lim H: Effect of variation of blood flow rate on blood pressure during hemodialysis. Annual Meeting of the American Society of Nephrology 2005, Philadelphia, PA. J Am Soc Nephrol 2005; 16: 39A.
73. TRIVEDI H: Vitamin D Deficiency in Chronic Kidney Disease. Annual Meeting of the American Society of Nephrology 2005, Philadelphia, PA. J Am Soc Nephrol 2005; 16: 757A.
74. TRIVEDI H, Lu N: Increased odds of non-cardiovascular death in dialysis subjects with pre-existing cardiovascular disease. Annual Meeting of the American Society of Nephrology 2006, San Diego, CA.
75. TRIVEDI H, Lu N: Serious cardiac events in incident dialysis patients with and without coronary disease. Annual Meeting of the American Society of Nephrology 2006, San Diego, CA. J Am Soc Nephrol 2006; 17: 311A.
76. TRIVEDI H, Whaley-Connell A, Lu N: Slowing of rate of decline of renal function after initiation of rosiglitazone for control of diabetes. Annual Meeting of the American Society of Nephrology 2006, San Diego, CA. J Am Soc Nephrol 2006; 17: 310A.
77. Chan MR, Dall AT, Fletcher KE, Lu N, TRIVEDI H: The effects of late nephrology referral of patients with chronic kidney disease - A meta-analysis. Annual Meeting of the American Society of Nephrology 2006, San Diego, CA. J Am Soc Nephrol 2006; 17: 646A.
78. Batwara R, Raman L, Benjamin H, TRIVEDI H: Lack of nephrotoxicity of gadodiamide in unselected hospitalized patients. Annual Meeting of the American Society of Nephrology 2006, San Diego, CA. J Am Soc Nephrol 2006; 17: 770A.
79. Aggarwal N, TRIVEDI H. Health care issues in end-stage renal disease and patients' knowledge of medical therapy. Annual Meeting of the American Society of Nephrology 2007, San Francisco, CA. J Am Soc Nephrol 2007; 18: 299A.
80. TRIVEDI H, Xiang Q, Klein JP. Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients. Annual Meeting of the American Society of Nephrology 2008, Philadelphia, PA. J Am Soc Nephrol 2008; 19: 724A.
81. Nadella R, Szabo A, TRIVEDI H. Hydration with sodium bicarbonate for the prevention of contrast-induced nephropathy. Annual Meeting of the American Society of Nephrology 2009, San Diego, CA. J Am Soc Nephrol 2009; 20: 599A.
82. Sujeet K, Anushayanathan A, TRIVEDI H. Spontaneous tumor lysis syndrome due to a neuroendocrine tumor. National Kidney Foundation Spring Clinical Meeting 2010, Orlando, FL. Am J Kidney Dis 2010; 55:A105.
83. Raff H, TRIVEDI H. Assessment of the circadian rhythm of the HPA axis in end-stage renal disease (ESRD) using salivary and serum cortisol. ENDO 2010, San Diego, CA. Endocr Rev 2010: 31:S1575.
84. TRIVEDI H, Szabo A, Hariharan S. Changing trends in rates of deceased donor renal transplantation. American Transplant Congress 2010, San Diego, CA. Am J Transplant 2010; 10 (suppl 4):336.
85. INVITED BOOK REVIEW
86. TRIVEDI H. Principles and Practice of Dialysis. By William L. Heinrich, 4th ed, Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, PA, 2009. JAMA 2011; 305:1141-1142.
87. ABSTRACTS PUBLISHED
88. TRIVEDI H, Lal SM, Ross G, Jr. Does hypocholesterolemia cause cyclosporine neurotoxicity? ASAIO Abstract Book 1994; S52.
89. Lal SM, TRIVEDI H, Van Stone J, Ross G, Jr. Dietary therapy does not reduce the elevated cholesterol in renal transplant patients. ASAIO Abstract Book 1994; S 52.
90. TRIVEDI H, Lal SM. A prospective, randomized, open-labeled cross over trial of fosinopril and theophylline in post renal transplant erythrocytosis. J Am Soc Nephrol 2002; 13: 566A.
91. TRIVEDI H. Effect of rosiglitazone on the progression of renal failure in diabetic subjects. J Am Soc Nephrol 2003; 14: 803A.
92. TRIVEDI H. Variation in phosphate levels in ESRD subjects. J Am Soc Nephrol 2003; 14: 898A.
93. TRIVEDI H, Moore H, Atalla J. Analysis of circadian and post-prandial variation in phosphate levels in hemodialysis subjects. J Am Soc Nephrol 2004; 15: 860A.
94. TRIVEDI H, Daram S, Szabo A, Bartorelli A, Marenzi G. High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy. J Am Soc Nephrol 2008; 19: 985A.
95. Hannan M, TRIVEDI H. Effect of a phosphate-controlled diet on phosphorus levels in chronic kidney disease. Abstract proceedings of the 10th International Conference, Functional Foods and bioactive compounds in Health and Disease; Science and Practice 2012, Santa Barbara, CA.
96. TRIVEDI H, Hannan M, Raff H. Circadian variation of phosphorus in end-stage renal disease. Abstracts proceedings of the 10th International Conference, Functional Foods and bioactive compounds in Health and Disease; Science and Practice 2012, Santa Barbara, CA.